若年性黄斑変性症（シュタルガルト病）治療の世界市場：市場規模・現状・予測

• 英文タイトル：Global Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Size, Status and Forecast 2019-2025

• レポートコード：QYR9ST03668 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

※当調査レポートでは、若年性黄斑変性症（シュタルガルト病）治療の世界市場について調査・分析し、若年性黄斑変性症（シュタルガルト病）治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（幹細胞療法、遺伝子療法、その他）、用途別（病院、眼科、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の若年性黄斑変性症（シュタルガルト病）治療市場動向 ・主要企業別マーケットシェア ・若年性黄斑変性症（シュタルガルト病）治療の種類別市場規模2014-2019 （幹細胞療法、遺伝子療法、その他） ・若年性黄斑変性症（シュタルガルト病）治療の用途別市場規模2014-2019 （病院、眼科、その他） ・若年性黄斑変性症（シュタルガルト病）治療の北米市場：主要企業・種類別/用途別市場規模 ・若年性黄斑変性症（シュタルガルト病）治療のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・若年性黄斑変性症（シュタルガルト病）治療の中国市場：主要企業・種類別/用途別市場規模 ・若年性黄斑変性症（シュタルガルト病）治療の日本国内市場：主要企業・種類別/用途別市場規模 ・若年性黄斑変性症（シュタルガルト病）治療の東南アジア市場：主要企業・種類別/用途別市場規模 ・若年性黄斑変性症（シュタルガルト病）治療のインド市場：主要企業・種類別/用途別市場規模 ・若年性黄斑変性症（シュタルガルト病）治療の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Sanofi、Bayer、Roche、Pfizer、Allergan、Gilead Sciences、Kubota Pharmaceutical、Alkeus Pharmaceuticals、Astellas Pharma、Ferrer Corporate） ・若年性黄斑変性症（シュタルガルト病）治療の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ...

Macular degeneration is a group of eye disease commonly found among children and adults. There are various types of macular degeneration affecting the teens such as Cone-Rod Dystrophy, Best disease, Stargardt disease, Corneal Dystrophy, and Fuch’s Dystrophy.Asia Pacific is expected to be the fastest growing market owing to the availability of skilled professional such as ophthalmologist, and eye surgeons. Additionally, improving healthcare infrastructure in developing countries like India is further fuelling the growth of juvenile macular degeneration market. China and India contribute to the growth of the market.
In 2018, the global Juvenile Macular Degeneration (Stargardt Disease) Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Juvenile Macular Degeneration (Stargardt Disease) Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Juvenile Macular Degeneration (Stargardt Disease) Treatment development in United States, Europe and China.

The key players covered in this study
Sanofi
Bayer
Roche
Pfizer
Allergan
Gilead Sciences
Kubota Pharmaceutical
Alkeus Pharmaceuticals
Astellas Pharma
Ferrer Corporate

Market segment by Type, the product can be split into
Stem Cell Therapy
Gene Therapy
Others

Market segment by Application, split into
Hospitals
Eye Clinics
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Juvenile Macular Degeneration (Stargardt Disease) Treatment status, future forecast, growth opportunity, key market and key players.
To present the Juvenile Macular Degeneration (Stargardt Disease) Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Juvenile Macular Degeneration (Stargardt Disease) Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

---

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Stem Cell Therapy
1.4.3 Gene Therapy
1.4.4 Others
1.5 Market by Application
1.5.1 Global Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Eye Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Size
2.2 Juvenile Macular Degeneration (Stargardt Disease) Treatment Growth Trends by Regions
2.2.1 Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Size by Regions (2014-2025)
2.2.2 Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Size by Manufacturers
3.1.1 Global Juvenile Macular Degeneration (Stargardt Disease) Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Juvenile Macular Degeneration (Stargardt Disease) Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Juvenile Macular Degeneration (Stargardt Disease) Treatment Key Players Head office and Area Served
3.3 Key Players Juvenile Macular Degeneration (Stargardt Disease) Treatment Product/Solution/Service
3.4 Date of Enter into Juvenile Macular Degeneration (Stargardt Disease) Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Size by Type (2014-2019)
4.2 Global Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Size by Application (2014-2019)

5 United States
5.1 United States Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Size (2014-2019)
5.2 Juvenile Macular Degeneration (Stargardt Disease) Treatment Key Players in United States
5.3 United States Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Size by Type
5.4 United States Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Size by Application

6 Europe
6.1 Europe Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Size (2014-2019)
6.2 Juvenile Macular Degeneration (Stargardt Disease) Treatment Key Players in Europe
6.3 Europe Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Size by Type
6.4 Europe Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Size by Application

7 China
7.1 China Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Size (2014-2019)
7.2 Juvenile Macular Degeneration (Stargardt Disease) Treatment Key Players in China
7.3 China Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Size by Type
7.4 China Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Size by Application

8 Japan
8.1 Japan Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Size (2014-2019)
8.2 Juvenile Macular Degeneration (Stargardt Disease) Treatment Key Players in Japan
8.3 Japan Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Size by Type
8.4 Japan Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Size (2014-2019)
9.2 Juvenile Macular Degeneration (Stargardt Disease) Treatment Key Players in Southeast Asia
9.3 Southeast Asia Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Size by Type
9.4 Southeast Asia Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Size by Application

10 India
10.1 India Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Size (2014-2019)
10.2 Juvenile Macular Degeneration (Stargardt Disease) Treatment Key Players in India
10.3 India Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Size by Type
10.4 India Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Size (2014-2019)
11.2 Juvenile Macular Degeneration (Stargardt Disease) Treatment Key Players in Central & South America
11.3 Central & South America Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Size by Type
11.4 Central & South America Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Size by Application

12 International Players Profiles
12.1 Sanofi
12.1.1 Sanofi Company Details
12.1.2 Company Description and Business Overview
12.1.3 Juvenile Macular Degeneration (Stargardt Disease) Treatment Introduction
12.1.4 Sanofi Revenue in Juvenile Macular Degeneration (Stargardt Disease) Treatment Business (2014-2019)
12.1.5 Sanofi Recent Development
12.2 Bayer
12.2.1 Bayer Company Details
12.2.2 Company Description and Business Overview
12.2.3 Juvenile Macular Degeneration (Stargardt Disease) Treatment Introduction
12.2.4 Bayer Revenue in Juvenile Macular Degeneration (Stargardt Disease) Treatment Business (2014-2019)
12.2.5 Bayer Recent Development
12.3 Roche
12.3.1 Roche Company Details
12.3.2 Company Description and Business Overview
12.3.3 Juvenile Macular Degeneration (Stargardt Disease) Treatment Introduction
12.3.4 Roche Revenue in Juvenile Macular Degeneration (Stargardt Disease) Treatment Business (2014-2019)
12.3.5 Roche Recent Development
12.4 Pfizer
12.4.1 Pfizer Company Details
12.4.2 Company Description and Business Overview
12.4.3 Juvenile Macular Degeneration (Stargardt Disease) Treatment Introduction
12.4.4 Pfizer Revenue in Juvenile Macular Degeneration (Stargardt Disease) Treatment Business (2014-2019)
12.4.5 Pfizer Recent Development
12.5 Allergan
12.5.1 Allergan Company Details
12.5.2 Company Description and Business Overview
12.5.3 Juvenile Macular Degeneration (Stargardt Disease) Treatment Introduction
12.5.4 Allergan Revenue in Juvenile Macular Degeneration (Stargardt Disease) Treatment Business (2014-2019)
12.5.5 Allergan Recent Development
12.6 Gilead Sciences
12.6.1 Gilead Sciences Company Details
12.6.2 Company Description and Business Overview
12.6.3 Juvenile Macular Degeneration (Stargardt Disease) Treatment Introduction
12.6.4 Gilead Sciences Revenue in Juvenile Macular Degeneration (Stargardt Disease) Treatment Business (2014-2019)
12.6.5 Gilead Sciences Recent Development
12.7 Kubota Pharmaceutical
12.7.1 Kubota Pharmaceutical Company Details
12.7.2 Company Description and Business Overview
12.7.3 Juvenile Macular Degeneration (Stargardt Disease) Treatment Introduction
12.7.4 Kubota Pharmaceutical Revenue in Juvenile Macular Degeneration (Stargardt Disease) Treatment Business (2014-2019)
12.7.5 Kubota Pharmaceutical Recent Development
12.8 Alkeus Pharmaceuticals
12.8.1 Alkeus Pharmaceuticals Company Details
12.8.2 Company Description and Business Overview
12.8.3 Juvenile Macular Degeneration (Stargardt Disease) Treatment Introduction
12.8.4 Alkeus Pharmaceuticals Revenue in Juvenile Macular Degeneration (Stargardt Disease) Treatment Business (2014-2019)
12.8.5 Alkeus Pharmaceuticals Recent Development
12.9 Astellas Pharma
12.9.1 Astellas Pharma Company Details
12.9.2 Company Description and Business Overview
12.9.3 Juvenile Macular Degeneration (Stargardt Disease) Treatment Introduction
12.9.4 Astellas Pharma Revenue in Juvenile Macular Degeneration (Stargardt Disease) Treatment Business (2014-2019)
12.9.5 Astellas Pharma Recent Development
12.10 Ferrer Corporate
12.10.1 Ferrer Corporate Company Details
12.10.2 Company Description and Business Overview
12.10.3 Juvenile Macular Degeneration (Stargardt Disease) Treatment Introduction
12.10.4 Ferrer Corporate Revenue in Juvenile Macular Degeneration (Stargardt Disease) Treatment Business (2014-2019)
12.10.5 Ferrer Corporate Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Juvenile Macular Degeneration (Stargardt Disease) Treatment Key Market Segments
Table Key Players Juvenile Macular Degeneration (Stargardt Disease) Treatment Covered
Table Global Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Size Market Share by Type 2014-2025
Figure Stem Cell Therapy Figures
Table Key Players of Stem Cell Therapy
Figure Gene Therapy Figures
Table Key Players of Gene Therapy
Figure Others Figures
Table Key Players of Others
Table Global Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Eye Clinics Case Studies
Figure Others Case Studies
Figure Juvenile Macular Degeneration (Stargardt Disease) Treatment Report Years Considered
Table Global Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Size 2014-2025 (Million US$)
Figure Global Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Size by Regions 2014-2025 (Million US$)
Table Global Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Size by Regions 2014-2019 (Million US$)
Table Global Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Share by Regions 2014-2019
Figure Global Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Share by Regions 2014-2019
Figure Global Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Share by Regions 2019
Table Market Top Trends
Table Global Juvenile Macular Degeneration (Stargardt Disease) Treatment Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Share by Manufacturers (2014-2019)
Figure Global Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Share by Manufacturers in 2018
Table Global Juvenile Macular Degeneration (Stargardt Disease) Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Juvenile Macular Degeneration (Stargardt Disease) Treatment Product/Solution/Service
Table Date of Enter into Juvenile Macular Degeneration (Stargardt Disease) Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Size Share by Type (2014-2019)
Figure Global Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Size Market Share by Type (2014-2019)
Table Global Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Size Share by Application (2014-2019)
Figure Global Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Size Market Share by Application (2014-2019)
Figure Global Juvenile Macular Degeneration (Stargardt Disease) Treatment Revenue Market Share by Application in 2018
Figure United States Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Size 2014-2019 (Million US$)
Table United States Key Players Juvenile Macular Degeneration (Stargardt Disease) Treatment Revenue (2018-2019) (Million US$)
Table United States Key Players Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Share (2018-2019)
Table United States Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Size by Type (2014-2019) (Million US$)
Table United States Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Share by Type (2014-2019)
Table United States Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Size by Application (2014-2019) (Million US$)
Table United States Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Share by Application (2014-2019)
Figure Europe Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Juvenile Macular Degeneration (Stargardt Disease) Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Share (2018-2019)
Table Europe Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Size by Type (2014-2019) (Million US$)
Table Europe Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Share by Type (2014-2019)
Table Europe Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Size by Application (2014-2019) (Million US$)
Table Europe Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Share by Application (2014-2019)
Figure China Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Juvenile Macular Degeneration (Stargardt Disease) Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Share (2018-2019)
Table China Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Size by Type (2014-20189) (Million US$)
Table China Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Share by Type (2014-2019)
Table China Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Size by Application (2014-2019) (Million US$)
Table China Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Share by Application (2014-2019)
Figure Japan Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Juvenile Macular Degeneration (Stargardt Disease) Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Share (2018-2019)
Table Japan Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Size by Type (2014-2019) (Million US$)
Table Japan Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Share by Type (2014-2019)
Table Japan Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Size by Application (2014-2019) (Million US$)
Table Japan Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Share by Application (2014-2019)
Figure Southeast Asia Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Juvenile Macular Degeneration (Stargardt Disease) Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Share (2018-2019)
Table Southeast Asia Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Share by Type (2014-2019)
Table Southeast Asia Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Share by Application (2014-2019)
Figure India Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Juvenile Macular Degeneration (Stargardt Disease) Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Share (2018-2019)
Table India Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Size by Type (2014-2019) (Million US$)
Table India Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Share by Type (2014-2019)
Table India Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Size by Application (2014-2019) (Million US$)
Table India Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Share by Application (2014-2019)
Figure Central & South America Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Juvenile Macular Degeneration (Stargardt Disease) Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Share (2018-2019)
Table Central & South America Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Size by Type (2014-2019) (Million US$)
Table Central & South America Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Share by Type (2014-2019)
Table Central & South America Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Size by Application (2014-2019) (Million US$)
Table Central & South America Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Share by Application (2014-2019)
Table Sanofi Company Details
Table Sanofi Revenue in Juvenile Macular Degeneration (Stargardt Disease) Treatment Business (2014-2019) (Million US$)
Figure Sanofi Revenue Growth Rate in Juvenile Macular Degeneration (Stargardt Disease) Treatment Business (2014-2019)
Table Sanofi Recent Development
Table Bayer Company Details
Table Bayer Revenue in Juvenile Macular Degeneration (Stargardt Disease) Treatment Business (2014-2019)(Million US$)
Figure Bayer Revenue Growth Rate in Juvenile Macular Degeneration (Stargardt Disease) Treatment Business (2014-2019)
Table Bayer Recent Development
Table Roche Company Details
Table Roche Revenue in Juvenile Macular Degeneration (Stargardt Disease) Treatment Business (2014-2019)(Million US$)
Figure Roche Revenue Growth Rate in Juvenile Macular Degeneration (Stargardt Disease) Treatment Business (2014-2019)
Table Roche Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Juvenile Macular Degeneration (Stargardt Disease) Treatment Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Juvenile Macular Degeneration (Stargardt Disease) Treatment Business (2014-2019)
Table Pfizer Recent Development
Table Allergan Company Details
Table Allergan Revenue in Juvenile Macular Degeneration (Stargardt Disease) Treatment Business (2014-2019)(Million US$)
Figure Allergan Revenue Growth Rate in Juvenile Macular Degeneration (Stargardt Disease) Treatment Business (2014-2019)
Table Allergan Recent Development
Table Gilead Sciences Company Details
Table Gilead Sciences Revenue in Juvenile Macular Degeneration (Stargardt Disease) Treatment Business (2014-2019)(Million US$)
Figure Gilead Sciences Revenue Growth Rate in Juvenile Macular Degeneration (Stargardt Disease) Treatment Business (2014-2019)
Table Gilead Sciences Recent Development
Table Kubota Pharmaceutical Company Details
Table Kubota Pharmaceutical Revenue in Juvenile Macular Degeneration (Stargardt Disease) Treatment Business (2014-2019)(Million US$)
Figure Kubota Pharmaceutical Revenue Growth Rate in Juvenile Macular Degeneration (Stargardt Disease) Treatment Business (2014-2019)
Table Kubota Pharmaceutical Recent Development
Table Alkeus Pharmaceuticals Company Details
Table Alkeus Pharmaceuticals Revenue in Juvenile Macular Degeneration (Stargardt Disease) Treatment Business (2014-2019)(Million US$)
Figure Alkeus Pharmaceuticals Revenue Growth Rate in Juvenile Macular Degeneration (Stargardt Disease) Treatment Business (2014-2019)
Table Alkeus Pharmaceuticals Recent Development
Table Astellas Pharma Company Details
Table Astellas Pharma Revenue in Juvenile Macular Degeneration (Stargardt Disease) Treatment Business (2014-2019)(Million US$)
Figure Astellas Pharma Revenue Growth Rate in Juvenile Macular Degeneration (Stargardt Disease) Treatment Business (2014-2019)
Table Astellas Pharma Recent Development
Table Ferrer Corporate Company Details
Table Ferrer Corporate Revenue in Juvenile Macular Degeneration (Stargardt Disease) Treatment Business (2014-2019)(Million US$)
Figure Ferrer Corporate Revenue Growth Rate in Juvenile Macular Degeneration (Stargardt Disease) Treatment Business (2014-2019)
Table Ferrer Corporate Recent Development
Table Global Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Size Share by Regions (2019-2025)
Figure Global Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Size Share by Regions in 2025
Figure United States Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Size by Product (2019-2025)
Figure Global Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Size by Product in 2025
Table Global Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Size by Application (2019-2025)
Figure Global Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

---